BioSpace News Archive

Policy

Ipsen Receives Positive CHMP Opinion for Cabometyx® (cabozantinib) for the First-Line Treatment of Adults with Intermediate- or Poor- Risk Advanced Renal Cell Carcinoma

Cabozantinib is the first and only monotherapy to demonstrate superior clinical efficacy over sunitinib in treatment-naïve patients with intermediate- or poor-risk aRCC.

March 23, 2018
·
13 min read
FDA

Canon Medical Systems’ Premium Ultrasound Provides New and Unique Features for a Wide Range of Liver Analysis

Industry’s Most Comprehensive Liver Analysis Suite with Attenuation Imaging and Shear Wave Dispersion

March 23, 2018
·
3 min read
Pharm Country

Anticancer Agent LENVIMA® Approved for Additional Indication of Unresectable Hepatocellular Carcinoma in Japan, First Approval Worldwide for LENVIMA for HCC

First New Front-Line Treatment Option for HCC Approved in Japan in Nearly 10 Years

March 23, 2018
·
40 min read
Job Trends

Caris Life Sciences Announces Published Results Showing that its ADAPT Biotargeting System Effectively Stratified Breast Cancer Patients Based on Their Benefit from Trastuzumab Treatment (Herceptin)

Data featured in Nature Communications showed ADAPT Biotargeting System significantly out-performed industry standard HER2 testing

March 23, 2018
·
4 min read
Business

Can-Fite Reports 2017 Financial Results & Provides Clinical Update

A multi-million dollar agreement has been signed with Gebro Holdings for the distribution of Piclidenoson in 3 European Countries

March 23, 2018
·
14 min read
Job Trends

HER Foundation Helps UCLA, USC and 23&Me Link Debilitating Pregnancy Illness to Two Genes

A breakthrough for women suffering from the severe pregnancy illness Hyperemesis Gravidarum.

March 23, 2018
·
3 min read
Business

Nuvo Pharmaceuticals Announces 2017 Fourth Quarter and Year-End Results

Nuvo to Host Conference Call/Audio Webcast March 23 at 8:30 a.m. ET

March 23, 2018
·
22 min read
Biotech Beach

Male Birth Control Pill Shows Promise

A breakthrough in oral male contraception, researchers show feasibility of “the pill” for men.

March 23, 2018
·
2 min read
Drug Development

Pfizer Reports Top-Line Results from a Study of CHANTIX®/CHAMPIX® (varenicline) in Adolescent Smokers

The study is a regulatory post marketing commitment for CHANTIX/CHAMPIX in the U.S. and EU for adolescents 12-16 years and 12-17 years of age, respectively.

March 23, 2018
·
7 min read
FDA

Smiths Medical Announces US Launch of the DeltaVen® Closed System Catheter and FDA Clearance

DeltaVen® is the next advancement in Peripheral IV Catheters.

March 23, 2018
·
1 min read